Please log in to determine if you are eligible to purchase PT Programs.
HUMAN PAPILLOMAVIRUS, MIXED MEDIA - CHPVJ
CHPVJ
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
HPV 5 Three shipments per year
High‑risk HPV genotyping (optional) 5

Additional Information

  • Each laboratory should choose the program that best reflects the transport media received in its facility. For program CHPVJ, participants must provide results for all three media types.
  • For laboratories that perform HPV genotyping using ThinPrep PreservCyt or SurePath Preservative Fluid transport mediums on site, programs CHPVM, CHPVK, and select samples of program CHPVJ provide an opportunity to report specific HPV genotypes.
  • The CAP does not report genotyping responses to the CMS.

Program Information

  • Five simulated cervical specimens
  • Combination of Digene, ThinPrep PreservCyt, and SurePath transport mediums

Shipping Schedule

  • Shipment A: February 28
  • Shipment B: August 1
  • Shipment C: December 12






Customers Who Bought This Item Also Bought
CAP Practical Guide to Gynecologic Cytopathology: Morphology, Management, and Molecular Methods
VIEW DETAILS >